Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Robert F. Kennedy Jr. has criticized companies making weight-loss drugs such as Ozempic. He has blamed America’s obesity ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

These weight loss medications, administered via injections, work by mimicking a hormone called GLP-1, which helps regulate appetite and blood sugar levels.